title: [Thrombosis and DIC in hematological malignancies].
authors.forename: Hidesaku
authors.initials: H
authors.lastname: Asakura
mesh_terms: D017306:Annexin A2 / Q000378:metabolism / Q000502:physiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D016207:Cytokines; D004211:Disseminated Intravascular Coagulation / Q000145:classification / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D004347:Drug Interactions; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects; D018180:Thrombomodulin; D014212:Tretinoin / Q000494:pharmacology / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control
chemical_list: C472822:ANXA2 protein, human; D017306:Annexin A2; D000970:Antineoplastic Agents; D016207:Cytokines; D018180:Thrombomodulin; D013792:Thalidomide; D014212:Tretinoin; D001215:Asparaginase